nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—CYP2D6—breast cancer	0.358	1	CbGaD
Trospium—Methadone—Tamoxifen—breast cancer	0.205	1	CrCrCtD
Trospium—CYP2D6—Idarubicin—breast cancer	0.032	0.414	CbGbCtD
Trospium—CYP2D6—Vinorelbine—breast cancer	0.0156	0.202	CbGbCtD
Trospium—CYP2D6—Tamoxifen—breast cancer	0.0141	0.183	CbGbCtD
Trospium—CYP2D6—Vinblastine—breast cancer	0.00963	0.125	CbGbCtD
Trospium—CYP2D6—Doxorubicin—breast cancer	0.00592	0.0766	CbGbCtD
Trospium—Aclidinium—BCHE—breast cancer	0.000903	0.323	CrCbGaD
Trospium—Ipratropium bromide—CYP2D6—breast cancer	0.000306	0.11	CrCbGaD
Trospium—Darifenacin—CYP2D6—breast cancer	0.000282	0.101	CrCbGaD
Trospium—Ipratropium bromide—CYP3A4—breast cancer	0.000263	0.094	CrCbGaD
Trospium—Benzatropine—CYP2D6—breast cancer	0.000251	0.0897	CrCbGaD
Trospium—Darifenacin—CYP3A4—breast cancer	0.000242	0.0867	CrCbGaD
Trospium—Methadone—CYP19A1—breast cancer	0.000227	0.0813	CrCbGaD
Trospium—Methadone—CYP2D6—breast cancer	0.000124	0.0445	CrCbGaD
Trospium—Methadone—CYP3A4—breast cancer	0.000107	0.0382	CrCbGaD
Trospium—Asthenia—Irinotecan—breast cancer	0.000105	0.000342	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000104	0.000342	CcSEcCtD
Trospium—Stomatitis—Epirubicin—breast cancer	0.000104	0.00034	CcSEcCtD
Trospium—Urinary tract infection—Epirubicin—breast cancer	0.000104	0.000339	CcSEcCtD
Trospium—Dysuria—Doxorubicin—breast cancer	0.000103	0.000338	CcSEcCtD
Trospium—Decreased appetite—Paclitaxel—breast cancer	0.000103	0.000338	CcSEcCtD
Trospium—Dry mouth—Docetaxel—breast cancer	0.000103	0.000336	CcSEcCtD
Trospium—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000103	0.000336	CcSEcCtD
Trospium—Fatigue—Paclitaxel—breast cancer	0.000102	0.000335	CcSEcCtD
Trospium—Pollakiuria—Doxorubicin—breast cancer	0.000102	0.000334	CcSEcCtD
Trospium—Asthenia—Gemcitabine—breast cancer	0.000102	0.000333	CcSEcCtD
Trospium—Chest pain—Capecitabine—breast cancer	0.000102	0.000333	CcSEcCtD
Trospium—Constipation—Paclitaxel—breast cancer	0.000102	0.000333	CcSEcCtD
Trospium—Haematuria—Epirubicin—breast cancer	0.000102	0.000333	CcSEcCtD
Trospium—Confusional state—Docetaxel—breast cancer	0.000102	0.000333	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000101	0.000331	CcSEcCtD
Trospium—Urinary tract disorder—Methotrexate—breast cancer	0.000101	0.00033	CcSEcCtD
Trospium—Photosensitivity reaction—Doxorubicin—breast cancer	0.000101	0.00033	CcSEcCtD
Trospium—Anaphylactic shock—Docetaxel—breast cancer	0.000101	0.00033	CcSEcCtD
Trospium—Oedema—Docetaxel—breast cancer	0.000101	0.00033	CcSEcCtD
Trospium—Weight increased—Doxorubicin—breast cancer	0.000101	0.000329	CcSEcCtD
Trospium—Pruritus—Gemcitabine—breast cancer	0.0001	0.000329	CcSEcCtD
Trospium—Nausea—Thiotepa—breast cancer	0.0001	0.000328	CcSEcCtD
Trospium—Urethral disorder—Methotrexate—breast cancer	0.0001	0.000328	CcSEcCtD
Trospium—Infection—Docetaxel—breast cancer	0.0001	0.000328	CcSEcCtD
Trospium—Dry mouth—Capecitabine—breast cancer	9.95e-05	0.000326	CcSEcCtD
Trospium—Shock—Docetaxel—breast cancer	9.91e-05	0.000324	CcSEcCtD
Trospium—Nervous system disorder—Docetaxel—breast cancer	9.87e-05	0.000323	CcSEcCtD
Trospium—Pruritus—Fluorouracil—breast cancer	9.87e-05	0.000323	CcSEcCtD
Trospium—Infestation NOS—Doxorubicin—breast cancer	9.85e-05	0.000323	CcSEcCtD
Trospium—Infestation—Doxorubicin—breast cancer	9.85e-05	0.000323	CcSEcCtD
Trospium—Visual impairment—Methotrexate—breast cancer	9.84e-05	0.000322	CcSEcCtD
Trospium—Confusional state—Capecitabine—breast cancer	9.83e-05	0.000322	CcSEcCtD
Trospium—Tachycardia—Docetaxel—breast cancer	9.83e-05	0.000322	CcSEcCtD
Trospium—Feeling abnormal—Paclitaxel—breast cancer	9.79e-05	0.000321	CcSEcCtD
Trospium—Skin disorder—Docetaxel—breast cancer	9.78e-05	0.00032	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Doxorubicin—breast cancer	9.77e-05	0.00032	CcSEcCtD
Trospium—Oedema—Capecitabine—breast cancer	9.75e-05	0.000319	CcSEcCtD
Trospium—Gastrointestinal pain—Paclitaxel—breast cancer	9.71e-05	0.000318	CcSEcCtD
Trospium—Infection—Capecitabine—breast cancer	9.68e-05	0.000317	CcSEcCtD
Trospium—Erythema multiforme—Methotrexate—breast cancer	9.66e-05	0.000316	CcSEcCtD
Trospium—Dizziness—Irinotecan—breast cancer	9.63e-05	0.000315	CcSEcCtD
Trospium—Stomatitis—Doxorubicin—breast cancer	9.6e-05	0.000315	CcSEcCtD
Trospium—Shock—Capecitabine—breast cancer	9.59e-05	0.000314	CcSEcCtD
Trospium—Rhinitis—Epirubicin—breast cancer	9.58e-05	0.000314	CcSEcCtD
Trospium—Urinary tract infection—Doxorubicin—breast cancer	9.58e-05	0.000314	CcSEcCtD
Trospium—Nervous system disorder—Capecitabine—breast cancer	9.56e-05	0.000313	CcSEcCtD
Trospium—Eye disorder—Methotrexate—breast cancer	9.55e-05	0.000313	CcSEcCtD
Trospium—Tachycardia—Capecitabine—breast cancer	9.51e-05	0.000312	CcSEcCtD
Trospium—Cardiac disorder—Methotrexate—breast cancer	9.48e-05	0.00031	CcSEcCtD
Trospium—Skin disorder—Capecitabine—breast cancer	9.47e-05	0.00031	CcSEcCtD
Trospium—Urinary tract disorder—Epirubicin—breast cancer	9.44e-05	0.000309	CcSEcCtD
Trospium—Urticaria—Paclitaxel—breast cancer	9.44e-05	0.000309	CcSEcCtD
Trospium—Hyperhidrosis—Capecitabine—breast cancer	9.42e-05	0.000309	CcSEcCtD
Trospium—Oedema peripheral—Epirubicin—breast cancer	9.42e-05	0.000308	CcSEcCtD
Trospium—Haematuria—Doxorubicin—breast cancer	9.39e-05	0.000308	CcSEcCtD
Trospium—Connective tissue disorder—Epirubicin—breast cancer	9.39e-05	0.000308	CcSEcCtD
Trospium—Abdominal pain—Paclitaxel—breast cancer	9.39e-05	0.000308	CcSEcCtD
Trospium—Urethral disorder—Epirubicin—breast cancer	9.37e-05	0.000307	CcSEcCtD
Trospium—Angiopathy—Methotrexate—breast cancer	9.27e-05	0.000304	CcSEcCtD
Trospium—Vomiting—Mitoxantrone—breast cancer	9.26e-05	0.000303	CcSEcCtD
Trospium—Vomiting—Irinotecan—breast cancer	9.26e-05	0.000303	CcSEcCtD
Trospium—Dizziness—Fluorouracil—breast cancer	9.22e-05	0.000302	CcSEcCtD
Trospium—Visual impairment—Epirubicin—breast cancer	9.21e-05	0.000302	CcSEcCtD
Trospium—Mediastinal disorder—Methotrexate—breast cancer	9.21e-05	0.000302	CcSEcCtD
Trospium—Rash—Mitoxantrone—breast cancer	9.18e-05	0.000301	CcSEcCtD
Trospium—Rash—Irinotecan—breast cancer	9.18e-05	0.000301	CcSEcCtD
Trospium—Dermatitis—Irinotecan—breast cancer	9.18e-05	0.000301	CcSEcCtD
Trospium—Dermatitis—Mitoxantrone—breast cancer	9.18e-05	0.000301	CcSEcCtD
Trospium—Headache—Mitoxantrone—breast cancer	9.12e-05	0.000299	CcSEcCtD
Trospium—Headache—Irinotecan—breast cancer	9.12e-05	0.000299	CcSEcCtD
Trospium—Erythema multiforme—Epirubicin—breast cancer	9.04e-05	0.000296	CcSEcCtD
Trospium—Vomiting—Gemcitabine—breast cancer	9.02e-05	0.000295	CcSEcCtD
Trospium—Somnolence—Docetaxel—breast cancer	8.95e-05	0.000293	CcSEcCtD
Trospium—Rash—Gemcitabine—breast cancer	8.95e-05	0.000293	CcSEcCtD
Trospium—Dermatitis—Gemcitabine—breast cancer	8.94e-05	0.000293	CcSEcCtD
Trospium—Eye disorder—Epirubicin—breast cancer	8.93e-05	0.000293	CcSEcCtD
Trospium—Malnutrition—Methotrexate—breast cancer	8.89e-05	0.000291	CcSEcCtD
Trospium—Headache—Gemcitabine—breast cancer	8.89e-05	0.000291	CcSEcCtD
Trospium—Methadone—ABCB1—breast cancer	8.88e-05	0.0318	CrCbGaD
Trospium—Flushing—Epirubicin—breast cancer	8.87e-05	0.000291	CcSEcCtD
Trospium—Cardiac disorder—Epirubicin—breast cancer	8.87e-05	0.000291	CcSEcCtD
Trospium—Vomiting—Fluorouracil—breast cancer	8.87e-05	0.000291	CcSEcCtD
Trospium—Rhinitis—Doxorubicin—breast cancer	8.87e-05	0.00029	CcSEcCtD
Trospium—Dyspepsia—Docetaxel—breast cancer	8.86e-05	0.00029	CcSEcCtD
Trospium—Rash—Fluorouracil—breast cancer	8.8e-05	0.000288	CcSEcCtD
Trospium—Dermatitis—Fluorouracil—breast cancer	8.79e-05	0.000288	CcSEcCtD
Trospium—Decreased appetite—Docetaxel—breast cancer	8.75e-05	0.000287	CcSEcCtD
Trospium—Headache—Fluorouracil—breast cancer	8.74e-05	0.000286	CcSEcCtD
Trospium—Urinary tract disorder—Doxorubicin—breast cancer	8.73e-05	0.000286	CcSEcCtD
Trospium—Oedema peripheral—Doxorubicin—breast cancer	8.71e-05	0.000285	CcSEcCtD
Trospium—Dysgeusia—Methotrexate—breast cancer	8.71e-05	0.000285	CcSEcCtD
Trospium—Gastrointestinal disorder—Docetaxel—breast cancer	8.69e-05	0.000285	CcSEcCtD
Trospium—Connective tissue disorder—Doxorubicin—breast cancer	8.69e-05	0.000285	CcSEcCtD
Trospium—Fatigue—Docetaxel—breast cancer	8.68e-05	0.000284	CcSEcCtD
Trospium—Angiopathy—Epirubicin—breast cancer	8.67e-05	0.000284	CcSEcCtD
Trospium—Urethral disorder—Doxorubicin—breast cancer	8.67e-05	0.000284	CcSEcCtD
Trospium—Nausea—Mitoxantrone—breast cancer	8.65e-05	0.000283	CcSEcCtD
Trospium—Nausea—Irinotecan—breast cancer	8.65e-05	0.000283	CcSEcCtD
Trospium—Mediastinal disorder—Epirubicin—breast cancer	8.61e-05	0.000282	CcSEcCtD
Trospium—Constipation—Docetaxel—breast cancer	8.61e-05	0.000282	CcSEcCtD
Trospium—Back pain—Methotrexate—breast cancer	8.6e-05	0.000282	CcSEcCtD
Trospium—Dyspepsia—Capecitabine—breast cancer	8.58e-05	0.000281	CcSEcCtD
Trospium—Visual impairment—Doxorubicin—breast cancer	8.52e-05	0.000279	CcSEcCtD
Trospium—Asthenia—Paclitaxel—breast cancer	8.52e-05	0.000279	CcSEcCtD
Trospium—Decreased appetite—Capecitabine—breast cancer	8.47e-05	0.000278	CcSEcCtD
Trospium—Nausea—Gemcitabine—breast cancer	8.43e-05	0.000276	CcSEcCtD
Trospium—Gastrointestinal disorder—Capecitabine—breast cancer	8.42e-05	0.000276	CcSEcCtD
Trospium—Fatigue—Capecitabine—breast cancer	8.4e-05	0.000275	CcSEcCtD
Trospium—Pruritus—Paclitaxel—breast cancer	8.4e-05	0.000275	CcSEcCtD
Trospium—Vision blurred—Methotrexate—breast cancer	8.38e-05	0.000274	CcSEcCtD
Trospium—Erythema multiforme—Doxorubicin—breast cancer	8.36e-05	0.000274	CcSEcCtD
Trospium—Constipation—Capecitabine—breast cancer	8.34e-05	0.000273	CcSEcCtD
Trospium—Malnutrition—Epirubicin—breast cancer	8.32e-05	0.000273	CcSEcCtD
Trospium—Feeling abnormal—Docetaxel—breast cancer	8.3e-05	0.000272	CcSEcCtD
Trospium—Nausea—Fluorouracil—breast cancer	8.29e-05	0.000271	CcSEcCtD
Trospium—Eye disorder—Doxorubicin—breast cancer	8.27e-05	0.000271	CcSEcCtD
Trospium—Gastrointestinal pain—Docetaxel—breast cancer	8.23e-05	0.00027	CcSEcCtD
Trospium—Flushing—Doxorubicin—breast cancer	8.21e-05	0.000269	CcSEcCtD
Trospium—Cardiac disorder—Doxorubicin—breast cancer	8.21e-05	0.000269	CcSEcCtD
Trospium—Flatulence—Epirubicin—breast cancer	8.2e-05	0.000269	CcSEcCtD
Trospium—Dysgeusia—Epirubicin—breast cancer	8.15e-05	0.000267	CcSEcCtD
Trospium—Back pain—Epirubicin—breast cancer	8.05e-05	0.000264	CcSEcCtD
Trospium—Feeling abnormal—Capecitabine—breast cancer	8.03e-05	0.000263	CcSEcCtD
Trospium—Angiopathy—Doxorubicin—breast cancer	8.02e-05	0.000263	CcSEcCtD
Trospium—Muscle spasms—Epirubicin—breast cancer	8e-05	0.000262	CcSEcCtD
Trospium—Gastrointestinal pain—Capecitabine—breast cancer	7.97e-05	0.000261	CcSEcCtD
Trospium—Mediastinal disorder—Doxorubicin—breast cancer	7.97e-05	0.000261	CcSEcCtD
Trospium—Abdominal pain—Docetaxel—breast cancer	7.96e-05	0.000261	CcSEcCtD
Trospium—Dizziness—Paclitaxel—breast cancer	7.86e-05	0.000257	CcSEcCtD
Trospium—Vision blurred—Epirubicin—breast cancer	7.84e-05	0.000257	CcSEcCtD
Trospium—Urticaria—Capecitabine—breast cancer	7.74e-05	0.000254	CcSEcCtD
Trospium—Abdominal pain—Capecitabine—breast cancer	7.71e-05	0.000252	CcSEcCtD
Trospium—Malnutrition—Doxorubicin—breast cancer	7.7e-05	0.000252	CcSEcCtD
Trospium—Flatulence—Doxorubicin—breast cancer	7.59e-05	0.000248	CcSEcCtD
Trospium—Chest pain—Methotrexate—breast cancer	7.57e-05	0.000248	CcSEcCtD
Trospium—Vomiting—Paclitaxel—breast cancer	7.55e-05	0.000247	CcSEcCtD
Trospium—Dysgeusia—Doxorubicin—breast cancer	7.54e-05	0.000247	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.52e-05	0.000246	CcSEcCtD
Trospium—Rash—Paclitaxel—breast cancer	7.49e-05	0.000245	CcSEcCtD
Trospium—Dermatitis—Paclitaxel—breast cancer	7.48e-05	0.000245	CcSEcCtD
Trospium—Syncope—Epirubicin—breast cancer	7.46e-05	0.000244	CcSEcCtD
Trospium—Back pain—Doxorubicin—breast cancer	7.45e-05	0.000244	CcSEcCtD
Trospium—Headache—Paclitaxel—breast cancer	7.44e-05	0.000244	CcSEcCtD
Trospium—Muscle spasms—Doxorubicin—breast cancer	7.4e-05	0.000242	CcSEcCtD
Trospium—Palpitations—Epirubicin—breast cancer	7.35e-05	0.000241	CcSEcCtD
Trospium—Confusional state—Methotrexate—breast cancer	7.32e-05	0.00024	CcSEcCtD
Trospium—Loss of consciousness—Epirubicin—breast cancer	7.31e-05	0.00024	CcSEcCtD
Trospium—Anaphylactic shock—Methotrexate—breast cancer	7.26e-05	0.000238	CcSEcCtD
Trospium—Vision blurred—Doxorubicin—breast cancer	7.26e-05	0.000238	CcSEcCtD
Trospium—Asthenia—Docetaxel—breast cancer	7.22e-05	0.000237	CcSEcCtD
Trospium—Infection—Methotrexate—breast cancer	7.21e-05	0.000236	CcSEcCtD
Trospium—Pruritus—Docetaxel—breast cancer	7.12e-05	0.000233	CcSEcCtD
Trospium—Nervous system disorder—Methotrexate—breast cancer	7.12e-05	0.000233	CcSEcCtD
Trospium—Chest pain—Epirubicin—breast cancer	7.08e-05	0.000232	CcSEcCtD
Trospium—Nausea—Paclitaxel—breast cancer	7.06e-05	0.000231	CcSEcCtD
Trospium—Skin disorder—Methotrexate—breast cancer	7.05e-05	0.000231	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.04e-05	0.00023	CcSEcCtD
Trospium—Hyperhidrosis—Methotrexate—breast cancer	7.02e-05	0.00023	CcSEcCtD
Trospium—Asthenia—Capecitabine—breast cancer	6.99e-05	0.000229	CcSEcCtD
Trospium—Dry mouth—Epirubicin—breast cancer	6.93e-05	0.000227	CcSEcCtD
Trospium—Syncope—Doxorubicin—breast cancer	6.9e-05	0.000226	CcSEcCtD
Trospium—Pruritus—Capecitabine—breast cancer	6.9e-05	0.000226	CcSEcCtD
Trospium—Confusional state—Epirubicin—breast cancer	6.85e-05	0.000224	CcSEcCtD
Trospium—Palpitations—Doxorubicin—breast cancer	6.8e-05	0.000223	CcSEcCtD
Trospium—Oedema—Epirubicin—breast cancer	6.79e-05	0.000222	CcSEcCtD
Trospium—Anaphylactic shock—Epirubicin—breast cancer	6.79e-05	0.000222	CcSEcCtD
Trospium—Loss of consciousness—Doxorubicin—breast cancer	6.77e-05	0.000222	CcSEcCtD
Trospium—Infection—Epirubicin—breast cancer	6.75e-05	0.000221	CcSEcCtD
Trospium—Shock—Epirubicin—breast cancer	6.68e-05	0.000219	CcSEcCtD
Trospium—Nervous system disorder—Epirubicin—breast cancer	6.66e-05	0.000218	CcSEcCtD
Trospium—Dizziness—Docetaxel—breast cancer	6.66e-05	0.000218	CcSEcCtD
Trospium—Tachycardia—Epirubicin—breast cancer	6.63e-05	0.000217	CcSEcCtD
Trospium—Skin disorder—Epirubicin—breast cancer	6.6e-05	0.000216	CcSEcCtD
Trospium—Hyperhidrosis—Epirubicin—breast cancer	6.57e-05	0.000215	CcSEcCtD
Trospium—Chest pain—Doxorubicin—breast cancer	6.55e-05	0.000215	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.51e-05	0.000213	CcSEcCtD
Trospium—Somnolence—Methotrexate—breast cancer	6.45e-05	0.000211	CcSEcCtD
Trospium—Dizziness—Capecitabine—breast cancer	6.45e-05	0.000211	CcSEcCtD
Trospium—Dry mouth—Doxorubicin—breast cancer	6.41e-05	0.00021	CcSEcCtD
Trospium—Vomiting—Docetaxel—breast cancer	6.4e-05	0.00021	CcSEcCtD
Trospium—Dyspepsia—Methotrexate—breast cancer	6.39e-05	0.000209	CcSEcCtD
Trospium—Rash—Docetaxel—breast cancer	6.35e-05	0.000208	CcSEcCtD
Trospium—Dermatitis—Docetaxel—breast cancer	6.34e-05	0.000208	CcSEcCtD
Trospium—Confusional state—Doxorubicin—breast cancer	6.34e-05	0.000208	CcSEcCtD
Trospium—Decreased appetite—Methotrexate—breast cancer	6.31e-05	0.000207	CcSEcCtD
Trospium—Headache—Docetaxel—breast cancer	6.31e-05	0.000207	CcSEcCtD
Trospium—Oedema—Doxorubicin—breast cancer	6.28e-05	0.000206	CcSEcCtD
Trospium—Anaphylactic shock—Doxorubicin—breast cancer	6.28e-05	0.000206	CcSEcCtD
Trospium—Gastrointestinal disorder—Methotrexate—breast cancer	6.27e-05	0.000205	CcSEcCtD
Trospium—Fatigue—Methotrexate—breast cancer	6.26e-05	0.000205	CcSEcCtD
Trospium—Infection—Doxorubicin—breast cancer	6.24e-05	0.000204	CcSEcCtD
Trospium—Vomiting—Capecitabine—breast cancer	6.2e-05	0.000203	CcSEcCtD
Trospium—Shock—Doxorubicin—breast cancer	6.18e-05	0.000202	CcSEcCtD
Trospium—Nervous system disorder—Doxorubicin—breast cancer	6.16e-05	0.000202	CcSEcCtD
Trospium—Rash—Capecitabine—breast cancer	6.15e-05	0.000201	CcSEcCtD
Trospium—Dermatitis—Capecitabine—breast cancer	6.14e-05	0.000201	CcSEcCtD
Trospium—Tachycardia—Doxorubicin—breast cancer	6.13e-05	0.000201	CcSEcCtD
Trospium—Headache—Capecitabine—breast cancer	6.11e-05	0.0002	CcSEcCtD
Trospium—Skin disorder—Doxorubicin—breast cancer	6.1e-05	0.0002	CcSEcCtD
Trospium—Hyperhidrosis—Doxorubicin—breast cancer	6.07e-05	0.000199	CcSEcCtD
Trospium—Somnolence—Epirubicin—breast cancer	6.04e-05	0.000198	CcSEcCtD
Trospium—Nausea—Docetaxel—breast cancer	5.98e-05	0.000196	CcSEcCtD
Trospium—Feeling abnormal—Methotrexate—breast cancer	5.98e-05	0.000196	CcSEcCtD
Trospium—Dyspepsia—Epirubicin—breast cancer	5.98e-05	0.000196	CcSEcCtD
Trospium—Gastrointestinal pain—Methotrexate—breast cancer	5.93e-05	0.000194	CcSEcCtD
Trospium—Decreased appetite—Epirubicin—breast cancer	5.9e-05	0.000193	CcSEcCtD
Trospium—Gastrointestinal disorder—Epirubicin—breast cancer	5.86e-05	0.000192	CcSEcCtD
Trospium—Fatigue—Epirubicin—breast cancer	5.86e-05	0.000192	CcSEcCtD
Trospium—Constipation—Epirubicin—breast cancer	5.81e-05	0.00019	CcSEcCtD
Trospium—Nausea—Capecitabine—breast cancer	5.79e-05	0.00019	CcSEcCtD
Trospium—Urticaria—Methotrexate—breast cancer	5.77e-05	0.000189	CcSEcCtD
Trospium—Abdominal pain—Methotrexate—breast cancer	5.74e-05	0.000188	CcSEcCtD
Trospium—Feeling abnormal—Epirubicin—breast cancer	5.6e-05	0.000183	CcSEcCtD
Trospium—Somnolence—Doxorubicin—breast cancer	5.59e-05	0.000183	CcSEcCtD
Trospium—Gastrointestinal pain—Epirubicin—breast cancer	5.55e-05	0.000182	CcSEcCtD
Trospium—Dyspepsia—Doxorubicin—breast cancer	5.53e-05	0.000181	CcSEcCtD
Trospium—Decreased appetite—Doxorubicin—breast cancer	5.46e-05	0.000179	CcSEcCtD
Trospium—Gastrointestinal disorder—Doxorubicin—breast cancer	5.43e-05	0.000178	CcSEcCtD
Trospium—Fatigue—Doxorubicin—breast cancer	5.42e-05	0.000177	CcSEcCtD
Trospium—Urticaria—Epirubicin—breast cancer	5.4e-05	0.000177	CcSEcCtD
Trospium—Constipation—Doxorubicin—breast cancer	5.37e-05	0.000176	CcSEcCtD
Trospium—Abdominal pain—Epirubicin—breast cancer	5.37e-05	0.000176	CcSEcCtD
Trospium—Asthenia—Methotrexate—breast cancer	5.21e-05	0.000171	CcSEcCtD
Trospium—Feeling abnormal—Doxorubicin—breast cancer	5.18e-05	0.00017	CcSEcCtD
Trospium—Gastrointestinal pain—Doxorubicin—breast cancer	5.14e-05	0.000168	CcSEcCtD
Trospium—Pruritus—Methotrexate—breast cancer	5.13e-05	0.000168	CcSEcCtD
Trospium—Urticaria—Doxorubicin—breast cancer	4.99e-05	0.000164	CcSEcCtD
Trospium—Abdominal pain—Doxorubicin—breast cancer	4.97e-05	0.000163	CcSEcCtD
Trospium—Asthenia—Epirubicin—breast cancer	4.87e-05	0.00016	CcSEcCtD
Trospium—Pruritus—Epirubicin—breast cancer	4.8e-05	0.000157	CcSEcCtD
Trospium—Dizziness—Methotrexate—breast cancer	4.8e-05	0.000157	CcSEcCtD
Trospium—Vomiting—Methotrexate—breast cancer	4.61e-05	0.000151	CcSEcCtD
Trospium—Rash—Methotrexate—breast cancer	4.58e-05	0.00015	CcSEcCtD
Trospium—Dermatitis—Methotrexate—breast cancer	4.57e-05	0.00015	CcSEcCtD
Trospium—Headache—Methotrexate—breast cancer	4.55e-05	0.000149	CcSEcCtD
Trospium—Asthenia—Doxorubicin—breast cancer	4.51e-05	0.000148	CcSEcCtD
Trospium—Dizziness—Epirubicin—breast cancer	4.49e-05	0.000147	CcSEcCtD
Trospium—Pruritus—Doxorubicin—breast cancer	4.45e-05	0.000146	CcSEcCtD
Trospium—Vomiting—Epirubicin—breast cancer	4.32e-05	0.000141	CcSEcCtD
Trospium—Nausea—Methotrexate—breast cancer	4.31e-05	0.000141	CcSEcCtD
Trospium—Rash—Epirubicin—breast cancer	4.28e-05	0.00014	CcSEcCtD
Trospium—Dermatitis—Epirubicin—breast cancer	4.28e-05	0.00014	CcSEcCtD
Trospium—Headache—Epirubicin—breast cancer	4.25e-05	0.000139	CcSEcCtD
Trospium—Dizziness—Doxorubicin—breast cancer	4.16e-05	0.000136	CcSEcCtD
Trospium—Nausea—Epirubicin—breast cancer	4.03e-05	0.000132	CcSEcCtD
Trospium—Vomiting—Doxorubicin—breast cancer	4e-05	0.000131	CcSEcCtD
Trospium—Rash—Doxorubicin—breast cancer	3.96e-05	0.00013	CcSEcCtD
Trospium—Dermatitis—Doxorubicin—breast cancer	3.96e-05	0.00013	CcSEcCtD
Trospium—Headache—Doxorubicin—breast cancer	3.94e-05	0.000129	CcSEcCtD
Trospium—Nausea—Doxorubicin—breast cancer	3.73e-05	0.000122	CcSEcCtD
Trospium—CHRM2—Signaling Pathways—CSF2—breast cancer	8.92e-06	0.000176	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—BCHE—breast cancer	8.9e-06	0.000176	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—H2AFX—breast cancer	8.9e-06	0.000176	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—IL2—breast cancer	8.9e-06	0.000176	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—RAF1—breast cancer	8.9e-06	0.000175	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CAV1—breast cancer	8.88e-06	0.000175	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—H2AFX—breast cancer	8.87e-06	0.000175	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—IL2—breast cancer	8.87e-06	0.000175	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NRG1—breast cancer	8.85e-06	0.000175	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—E2F1—breast cancer	8.84e-06	0.000174	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—E2F1—breast cancer	8.81e-06	0.000174	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	8.8e-06	0.000174	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SLC5A5—breast cancer	8.8e-06	0.000173	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—H2AFX—breast cancer	8.79e-06	0.000173	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—IL2—breast cancer	8.78e-06	0.000173	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	8.77e-06	0.000173	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—E2F1—breast cancer	8.73e-06	0.000172	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	8.68e-06	0.000171	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NQO1—breast cancer	8.5e-06	0.000168	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SLC2A1—breast cancer	8.5e-06	0.000168	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SPP1—breast cancer	8.49e-06	0.000168	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SPP1—breast cancer	8.46e-06	0.000167	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCL8—breast cancer	8.45e-06	0.000167	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCL8—breast cancer	8.43e-06	0.000166	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB3—breast cancer	8.4e-06	0.000166	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGFR2—breast cancer	8.39e-06	0.000165	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SPP1—breast cancer	8.38e-06	0.000165	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB3—breast cancer	8.37e-06	0.000165	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGFR2—breast cancer	8.36e-06	0.000165	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCL8—breast cancer	8.35e-06	0.000165	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB3—breast cancer	8.29e-06	0.000164	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP3A4—breast cancer	8.28e-06	0.000163	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGFR2—breast cancer	8.28e-06	0.000163	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP1B1—breast cancer	8.14e-06	0.000161	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CG—breast cancer	8.09e-06	0.000159	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL2—breast cancer	8.08e-06	0.000159	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL2—breast cancer	8.05e-06	0.000159	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TERT—breast cancer	8.05e-06	0.000159	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TERT—breast cancer	8.02e-06	0.000158	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—HSP90AA1—breast cancer	7.99e-06	0.000158	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL2—breast cancer	7.98e-06	0.000157	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TERT—breast cancer	7.95e-06	0.000157	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FGFR1—breast cancer	7.82e-06	0.000154	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FGFR1—breast cancer	7.79e-06	0.000154	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NCOA1—breast cancer	7.77e-06	0.000153	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FGFR1—breast cancer	7.72e-06	0.000152	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HIF1A—breast cancer	7.7e-06	0.000152	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HIF1A—breast cancer	7.67e-06	0.000151	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—STK11—breast cancer	7.66e-06	0.000151	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP19A1—breast cancer	7.66e-06	0.000151	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HIF1A—breast cancer	7.6e-06	0.00015	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—LEP—breast cancer	7.52e-06	0.000148	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—LEP—breast cancer	7.49e-06	0.000148	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CAV1—breast cancer	7.45e-06	0.000147	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CAV1—breast cancer	7.42e-06	0.000146	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—LEP—breast cancer	7.42e-06	0.000146	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KDR—breast cancer	7.36e-06	0.000145	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CAV1—breast cancer	7.35e-06	0.000145	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KDR—breast cancer	7.34e-06	0.000145	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KDR—breast cancer	7.27e-06	0.000143	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ESR1—breast cancer	7.18e-06	0.000142	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ESR1—breast cancer	7.15e-06	0.000141	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—COMT—breast cancer	7.12e-06	0.00014	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CD—breast cancer	7.11e-06	0.00014	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FN1—breast cancer	7.09e-06	0.00014	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GSTP1—breast cancer	7.09e-06	0.00014	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ESR1—breast cancer	7.08e-06	0.00014	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FN1—breast cancer	7.06e-06	0.000139	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ALB—breast cancer	7.02e-06	0.000138	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NFKBIA—breast cancer	7e-06	0.000138	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FN1—breast cancer	7e-06	0.000138	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—HMOX1—breast cancer	6.99e-06	0.000138	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NFKBIA—breast cancer	6.98e-06	0.000138	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ITPR1—breast cancer	6.97e-06	0.000138	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOTCH1—breast cancer	6.94e-06	0.000137	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOTCH1—breast cancer	6.91e-06	0.000136	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NFKBIA—breast cancer	6.91e-06	0.000136	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOTCH1—breast cancer	6.85e-06	0.000135	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CG—breast cancer	6.78e-06	0.000134	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—APC—breast cancer	6.78e-06	0.000134	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KIT—breast cancer	6.78e-06	0.000134	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—APC—breast cancer	6.76e-06	0.000133	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CG—breast cancer	6.76e-06	0.000133	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KIT—breast cancer	6.76e-06	0.000133	CbGpPWpGaD
Trospium—CHRM3—Metabolism—NOS3—breast cancer	6.71e-06	0.000132	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ABCB1—breast cancer	6.71e-06	0.000132	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGF—breast cancer	6.7e-06	0.000132	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—APC—breast cancer	6.7e-06	0.000132	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KIT—breast cancer	6.7e-06	0.000132	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CG—breast cancer	6.7e-06	0.000132	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGF—breast cancer	6.68e-06	0.000132	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGF—breast cancer	6.62e-06	0.000131	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—TYMS—breast cancer	6.59e-06	0.00013	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GSTM1—breast cancer	6.51e-06	0.000128	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NCOR1—breast cancer	6.51e-06	0.000128	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PLA2G4A—breast cancer	6.51e-06	0.000128	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—MAPK3—breast cancer	6.5e-06	0.000128	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—MAPK3—breast cancer	6.47e-06	0.000128	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—MAPK3—breast cancer	6.41e-06	0.000126	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—BRAF—breast cancer	6.38e-06	0.000126	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—BRAF—breast cancer	6.36e-06	0.000125	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—BRAF—breast cancer	6.29e-06	0.000124	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GPX1—breast cancer	6.24e-06	0.000123	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IGF1—breast cancer	6.21e-06	0.000122	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—AKT2—breast cancer	6.21e-06	0.000122	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CB—breast cancer	6.2e-06	0.000122	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IGF1—breast cancer	6.19e-06	0.000122	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—AKT2—breast cancer	6.19e-06	0.000122	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—EGFR—breast cancer	6.18e-06	0.000122	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP1A1—breast cancer	6.17e-06	0.000122	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—EGFR—breast cancer	6.16e-06	0.000122	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTGS2—breast cancer	6.14e-06	0.000121	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IGF1—breast cancer	6.13e-06	0.000121	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—AKT2—breast cancer	6.13e-06	0.000121	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ERCC2—breast cancer	6.12e-06	0.000121	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—EGFR—breast cancer	6.1e-06	0.00012	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CD—breast cancer	5.96e-06	0.000118	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CD—breast cancer	5.94e-06	0.000117	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	5.91e-06	0.000116	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SERPINE1—breast cancer	5.9e-06	0.000116	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	5.89e-06	0.000116	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CD—breast cancer	5.89e-06	0.000116	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SERPINE1—breast cancer	5.88e-06	0.000116	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—KRAS—breast cancer	5.84e-06	0.000115	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	5.83e-06	0.000115	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SERPINE1—breast cancer	5.82e-06	0.000115	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—KRAS—breast cancer	5.82e-06	0.000115	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—KRAS—breast cancer	5.76e-06	0.000114	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—MTHFR—breast cancer	5.75e-06	0.000114	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOS3—breast cancer	5.63e-06	0.000111	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOS3—breast cancer	5.61e-06	0.000111	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOS3—breast cancer	5.56e-06	0.00011	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	5.36e-06	0.000106	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTEN—breast cancer	5.35e-06	0.000106	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	5.35e-06	0.000105	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MDM2—breast cancer	5.34e-06	0.000105	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MDM2—breast cancer	5.32e-06	0.000105	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—RAF1—breast cancer	5.32e-06	0.000105	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CAV1—breast cancer	5.31e-06	0.000105	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—RAF1—breast cancer	5.31e-06	0.000105	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—RELA—breast cancer	5.3e-06	0.000105	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	5.29e-06	0.000104	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—RELA—breast cancer	5.28e-06	0.000104	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MDM2—breast cancer	5.27e-06	0.000104	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB2—breast cancer	5.27e-06	0.000104	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—RAF1—breast cancer	5.25e-06	0.000104	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB2—breast cancer	5.25e-06	0.000104	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—RELA—breast cancer	5.23e-06	0.000103	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB2—breast cancer	5.2e-06	0.000103	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MTOR—breast cancer	5.2e-06	0.000103	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CB—breast cancer	5.2e-06	0.000103	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MTOR—breast cancer	5.18e-06	0.000102	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CB—breast cancer	5.18e-06	0.000102	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CB—breast cancer	5.13e-06	0.000101	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MTOR—breast cancer	5.13e-06	0.000101	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCL8—breast cancer	4.99e-06	9.85e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCL8—breast cancer	4.98e-06	9.82e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—HRAS—breast cancer	4.96e-06	9.79e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—HRAS—breast cancer	4.95e-06	9.76e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCL8—breast cancer	4.93e-06	9.72e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—HRAS—breast cancer	4.9e-06	9.66e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1B—breast cancer	4.88e-06	9.62e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1B—breast cancer	4.86e-06	9.59e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CG—breast cancer	4.83e-06	9.54e-05	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—AKT1—breast cancer	4.82e-06	9.52e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1B—breast cancer	4.81e-06	9.5e-05	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—AKT1—breast cancer	4.81e-06	9.49e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CASP3—breast cancer	4.78e-06	9.43e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL2—breast cancer	4.77e-06	9.41e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CASP3—breast cancer	4.76e-06	9.4e-05	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—AKT1—breast cancer	4.76e-06	9.39e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL2—breast cancer	4.76e-06	9.38e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—IL6—breast cancer	4.75e-06	9.37e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—IL6—breast cancer	4.73e-06	9.34e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CASP3—breast cancer	4.72e-06	9.31e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL2—breast cancer	4.71e-06	9.29e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—IL6—breast cancer	4.69e-06	9.25e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCND1—breast cancer	4.65e-06	9.18e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—JUN—breast cancer	4.64e-06	9.16e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCND1—breast cancer	4.64e-06	9.15e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—JUN—breast cancer	4.63e-06	9.13e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CTNNB1—breast cancer	4.61e-06	9.09e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCND1—breast cancer	4.59e-06	9.06e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CTNNB1—breast cancer	4.59e-06	9.06e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—JUN—breast cancer	4.58e-06	9.04e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CTNNB1—breast cancer	4.55e-06	8.97e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MMP9—breast cancer	4.52e-06	8.91e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MMP9—breast cancer	4.5e-06	8.88e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1A—breast cancer	4.5e-06	8.88e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PTEN—breast cancer	4.49e-06	8.86e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1A—breast cancer	4.49e-06	8.85e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PTEN—breast cancer	4.48e-06	8.83e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MMP9—breast cancer	4.46e-06	8.8e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1A—breast cancer	4.44e-06	8.76e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PTEN—breast cancer	4.43e-06	8.74e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAPK8—breast cancer	4.39e-06	8.67e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—AKT1—breast cancer	4.38e-06	8.64e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAPK8—breast cancer	4.38e-06	8.64e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—AKT1—breast cancer	4.37e-06	8.61e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAPK8—breast cancer	4.34e-06	8.55e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—AKT1—breast cancer	4.32e-06	8.53e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CD—breast cancer	4.25e-06	8.38e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ALB—breast cancer	4.2e-06	8.28e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SRC—breast cancer	4.16e-06	8.21e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SRC—breast cancer	4.15e-06	8.19e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SRC—breast cancer	4.11e-06	8.11e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—VEGFA—breast cancer	4.06e-06	8e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—VEGFA—breast cancer	4.04e-06	7.98e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—STAT3—breast cancer	4.02e-06	7.92e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NOS3—breast cancer	4.01e-06	7.92e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—VEGFA—breast cancer	4e-06	7.9e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—STAT3—breast cancer	4e-06	7.9e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—STAT3—breast cancer	3.96e-06	7.82e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MAPK3—breast cancer	3.84e-06	7.57e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MAPK3—breast cancer	3.83e-06	7.54e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MAPK3—breast cancer	3.79e-06	7.47e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CA—breast cancer	3.78e-06	7.45e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MYC—breast cancer	3.73e-06	7.36e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TGFB1—breast cancer	3.72e-06	7.34e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MYC—breast cancer	3.72e-06	7.34e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TGFB1—breast cancer	3.71e-06	7.32e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CB—breast cancer	3.7e-06	7.31e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MYC—breast cancer	3.68e-06	7.27e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TGFB1—breast cancer	3.68e-06	7.25e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTGS2—breast cancer	3.67e-06	7.24e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGFR—breast cancer	3.65e-06	7.2e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGFR—breast cancer	3.64e-06	7.18e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGFR—breast cancer	3.6e-06	7.11e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KRAS—breast cancer	3.45e-06	6.8e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KRAS—breast cancer	3.44e-06	6.78e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KRAS—breast cancer	3.4e-06	6.71e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTEN—breast cancer	3.2e-06	6.31e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CA—breast cancer	3.17e-06	6.25e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CA—breast cancer	3.16e-06	6.23e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CA—breast cancer	3.13e-06	6.17e-05	CbGpPWpGaD
Trospium—CHRM3—Metabolism—AKT1—breast cancer	3.09e-06	6.09e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TP53—breast cancer	3.06e-06	6.05e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TP53—breast cancer	3.06e-06	6.03e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TP53—breast cancer	3.03e-06	5.97e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HRAS—breast cancer	2.93e-06	5.78e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HRAS—breast cancer	2.92e-06	5.76e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HRAS—breast cancer	2.89e-06	5.71e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—IL6—breast cancer	2.81e-06	5.53e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—IL6—breast cancer	2.8e-06	5.52e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—IL6—breast cancer	2.77e-06	5.46e-05	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—AKT1—breast cancer	2.59e-06	5.11e-05	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—AKT1—breast cancer	2.58e-06	5.09e-05	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—AKT1—breast cancer	2.55e-06	5.04e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CA—breast cancer	2.26e-06	4.45e-05	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—AKT1—breast cancer	1.84e-06	3.64e-05	CbGpPWpGaD
